We are live on ! Find out more
PSC

Prentiss Smith & Co Portfolio holdings

AUM $172M
1-Year Est. Return 21.18%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+21.18%
3 Year Est. Return
+55.24%
5 Year Est. Return
+52.07%
10 Year Est. Return
+229.25%
AUM
$193M
AUM Growth
-$328K
Cap. Flow
-$10.5M
Cap. Flow %
-5.46%
Top 10 Hldgs %
51.21%
Holding
277
New
8
Increased
17
Reduced
55
Closed
29

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$5.65M
2
ED icon
Consolidated Edison
ED
+$1.75M
3
META icon
Meta Platforms (Facebook)
META
+$59.5K
4
JNJ icon
Johnson & Johnson
JNJ
+$57.4K
5
POT
Potash Corp Of Saskatchewan
POT
+$39.8K

Top Sells

Rank Stock Value
1
INVN
Invensense Inc
INVN
+$5.75M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.41M
3
PKT
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
+$1.44M
4
QGENF
QIAGEN NV
QGENF
+$1.39M
5
UNP icon
Union Pacific
UNP
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 21.78%
2 Healthcare 15.87%
3 Financials 14.17%
4 Communication Services 13.08%
5 Consumer Staples 11.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VGK icon
176
Vanguard FTSE Europe ETF
VGK
$30.1B
$12K 0.01%
226
– –
AXP icon
177
American Express
AXP
$226B
$11K 0.01%
150
– –
STT icon
178
State Street
STT
$50.7B
$11K 0.01%
167
– –
SWC
179
DELISTED
Stillwater Mining Co
SWC
$11K 0.01%
1,000
– –
FLOW
180
DELISTED
FLOW INTL CORP
FLOW
$11K 0.01%
2,850
– –
DHR icon
181
Danaher
DHR
$138B
$10K 0.01%
223
– –
PBA icon
182
Pembina Pipeline
PBA
$29B
$10K 0.01%
297
– –
CAJ
183
DELISTED
Canon, Inc.
CAJ
$10K 0.01%
300
– –
VIVO
184
DELISTED
Meridian Bioscience Inc
VIVO
$9K ﹤0.01%
400
– –
HTS
185
DELISTED
HATTERAS FINANCIAL CORP
HTS
$9K ﹤0.01%
500
– –
IONS icon
186
Ionis Pharmaceuticals
IONS
$9.25B
$8K ﹤0.01%
200
– –
PBW icon
187
Invesco WilderHill Clean Energy ETF
PBW
$409M
$8K ﹤0.01%
250
– –
HYGS
188
DELISTED
Hydrogenics Corp
HYGS
$8K ﹤0.01%
631
– –
KAI icon
189
Kadant
KAI
$3.69B
$7K ﹤0.01%
200
– –
PAA icon
190
Plains All American Pipeline
PAA
$17.1B
$7K ﹤0.01%
140
– –
NLY icon
191
Annaly Capital Management
NLY
$16.9B
$6K ﹤0.01%
125
– –
AIG icon
192
American International
AIG
$42B
$5K ﹤0.01%
100
– –
EWZ icon
193
iShares MSCI Brazil ETF
EWZ
$9.08B
$5K ﹤0.01%
100
– –
K
194
DELISTED
Kellanova
K
$5K ﹤0.01%
84
– –
MDLZ icon
195
Mondelez International
MDLZ
$77.9B
$5K ﹤0.01%
167
– –
MET icon
196
MetLife
MET
$61.2B
$5K ﹤0.01%
112
– –
PKX icon
197
POSCO
PKX
$16.1B
$5K ﹤0.01%
70
– –
RDC
198
DELISTED
Rowan Companies Plc
RDC
$5K ﹤0.01%
140
– –
CLDX icon
199
Celldex Therapeutics
CLDX
$2.8B
$4K ﹤0.01%
7
– –
NWN icon
200
Northwest Natural Holdings
NWN
$2.16B
$4K ﹤0.01%
100
– –
6 7
8
9 10

Similar funds

CRFG
Columbia River Financial Group Vancouver, Washington $172M AUM 13.74% 1-Year Est. Return
TA
Tiptree Advisors New York $172M AUM 86.65% 1-Year Est. Return
BIA
Benchmark Investment Advisors Chicago, Illinois $172M AUM
GWCM
Godshalk Welsh Capital Management Radnor, Pennsylvania $172M AUM 16.03% 1-Year Est. Return
PWM
Peterson Wealth Management Sparks, Nevada $172M AUM 22.85% 1-Year Est. Return
SPF
South Plains Financial Lubbock, Texas $172M AUM 21.06% 1-Year Est. Return
AIG
Abbington Investment Group Westport, Connecticut $172M AUM
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $172M AUM 10.38% 1-Year Est. Return

Prentiss Smith & Co's Q3 2013 Portfolio in Review

As of Q3 2013, Prentiss Smith & Co held 277 positions worth $193M, down 0.17% from $193M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Prentiss Smith & Co withdrew a net $10.5M in Q3 2013, closing 29 positions and reducing 55 holdings. Its most notable exit was Invensense Inc, an estimated $5.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Prentiss Smith & Co opened a new position in Consolidated Edison worth $1.68M.

  • Prentiss Smith & Co's largest Q3 2013 buy was Consolidated Edison: 30,451 shares worth $1.68M.
  • Prentiss Smith & Co added most to Novartis in Q3 2013, an estimated $5.65M increase.
  • Prentiss Smith & Co's biggest Q3 2013 reduction was PROCERA NETWORKS INC NEW COM STK (DE), cutting an estimated $1.44M.
  • Prentiss Smith & Co fully exited Invensense Inc in Q3 2013, selling an estimated $5.75M.
  • Prentiss Smith & Co's ten largest holdings make up 51% of its $193M portfolio in Q3 2013.
  • Prentiss Smith & Co opened 8 new positions and closed 29 in Q3 2013.
  • Prentiss Smith & Co's portfolio value fell 0.17% quarter-over-quarter to $193M.

Based on Prentiss Smith & Co's 13F filing for Q3 2013, filed 1 Nov 2013.